{"id":"NCT03669588","sponsor":"argenx","briefTitle":"An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Trial to Evaluate the Efficacy, Safety and Tolerability of ARGX-113 in Patients With Myasthenia Gravis Having Generalized Muscle Weakness","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-08-22","primaryCompletion":"2020-04-06","completion":"2020-04-06","firstPosted":"2018-09-13","resultsPosted":"2022-02-08","lastUpdate":"2022-02-08"},"enrollment":167,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Generalized Myasthenia Gravis"],"interventions":[{"type":"BIOLOGICAL","name":"ARGX-113","otherNames":["efgartigimod"]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"ARGX-113","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"A randomized, double-blind, placebo controlled, multicenter Phase 3 trial to evaluate the efficacy, safety, tolerability, quality of life and impact on normal daily activities of ARGX-113 in patients with gMG.","primaryOutcome":{"measure":"Percentage of MG-ADL Responders During Cycle 1 (C1); Analyzed in the AChR-Ab Seropositive Population","timeFrame":"Baseline up to Day 63 (end of TC1)","effectByArm":[{"arm":"ARGX-113","deltaMin":67.7,"sd":null},{"arm":"Placebo","deltaMin":29.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":66,"countries":["United States","Belgium","Canada","Czechia","Denmark","France","Georgia","Germany","Hungary","Italy","Japan","Netherlands","Poland","Russia","Serbia","United Kingdom"]},"refs":{"pmids":["39068745","34146511"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":84},"commonTop":["Headache","Nasopharyngitis","Nausea","Diarrhoea","Upper respiratory tract infection"]}}